106 related articles for article (PubMed ID: 9021692)
1. High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results.
Mehta J; Powles R; Singhal S; Swansbury GJ; Millar B; Shepherd V; Bell J; Min T; Cabral S; Treleaven J
Leuk Lymphoma; 1996 Sep; 23(1-2):107-11. PubMed ID: 9021692
[TBL] [Abstract][Full Text] [Related]
2. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
[TBL] [Abstract][Full Text] [Related]
3. Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim).
Johnson RJ; Owen RG; Child JA; Morgan GJ; Barnard DL; Dickinson H; Ricketts S; Rawstron A; Evans P; Woodhead V; Major K; Robinson F; Smith GM
Br J Haematol; 1996 Jun; 93(4):863-8. PubMed ID: 8703818
[TBL] [Abstract][Full Text] [Related]
4. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
[TBL] [Abstract][Full Text] [Related]
5. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
[TBL] [Abstract][Full Text] [Related]
7. Mobilisation and reinfusion of Philadelphia negative peripheral blood mononuclear cells in chronic myeloid leukaemia with hydroxyurea and G-CSF.
Johnson RJ; Smith GM
Leuk Lymphoma; 1997 Nov; 27(5-6):401-15. PubMed ID: 9477122
[TBL] [Abstract][Full Text] [Related]
8. High dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukaemia.
Kuss BJ; Sage RE; Shepherd KM; Hardingham J; Nicola M
Leuk Lymphoma; 1993 May; 10(1-2):73-8. PubMed ID: 8374526
[TBL] [Abstract][Full Text] [Related]
9. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Olsson-Strömberg U; Höglund M; Björkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Löfvenberg E; Malm C; Nilsson PG; Paul C; Rödjer S; Stenke L; Tidefeldt U; Turesson I; Uden AM; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Leuk Lymphoma; 2006 Sep; 47(9):1768-73. PubMed ID: 17064986
[TBL] [Abstract][Full Text] [Related]
10. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
[TBL] [Abstract][Full Text] [Related]
11. Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.
Mehta J; Mijović A; Powles R; Pagliuca A; Singhal S; Czepulkowski B; Swansbury GJ; Treleaven J; Mufti GJ
Bone Marrow Transplant; 1996 Jan; 17(1):25-9. PubMed ID: 8673050
[TBL] [Abstract][Full Text] [Related]
12. Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon.
Reiffers J; Taylor K; Gluckman E; Gorin NC; Mahon FX; Micléa JM; Destrée D; Gautier L
Br J Haematol; 1998 Aug; 102(3):639-46. PubMed ID: 9722288
[TBL] [Abstract][Full Text] [Related]
13. Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea.
Carella AM; Frassoni F; Pollicardo N; Pungolino E; Podestà M; Giordano D; Ferrero R; Soracco M; Benvenuto F; Figari O
Bone Marrow Transplant; 1994; 14 Suppl 3():S34-7. PubMed ID: 7535152
[No Abstract] [Full Text] [Related]
14. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia.
Broughton CM; Sherrington P; Pender NT; Clark RE
Genes Chromosomes Cancer; 1997 Apr; 18(4):292-8. PubMed ID: 9087569
[TBL] [Abstract][Full Text] [Related]
15. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
Pratt G; Johnson RJ; Rawstron AC; Barnard DL; Morgan GJ; Smith GM
Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037
[TBL] [Abstract][Full Text] [Related]
16. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
17. Idarubicin-containing regimen and G-CSF are capable of recruiting CD34+/DR- cells with high proliferative potential which sustain Ph-negative polyclonal hematopoiesis.
Carella AM; Podestá M; Pollicardo N; Pungolino E; Raffo MR; Ferrero R; Bergamaschi G; Rosti V; Cazzola M; Saglio G
Leukemia; 1994 Jan; 8(1):212-3. PubMed ID: 7507192
[No Abstract] [Full Text] [Related]
18. Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy.
Singhal S; Mehta J; Desikan K; Siegel D; Singh J; Munshi N; Spoon D; Anaissie E; Ayers D; Barlogie B
Bone Marrow Transplant; 1999 Jul; 24(1):13-7. PubMed ID: 10435728
[TBL] [Abstract][Full Text] [Related]
19. Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia.
Carella AM
Leuk Lymphoma; 2001 Jan; 40(3-4):447-8. PubMed ID: 11426572
[No Abstract] [Full Text] [Related]
20. The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Hehlmann R; Heimpel H; Kolb HJ; Heinze B; Hochhaus A; Griesshammer M; Pralle H; Queisser WP; Essers U; Falge C
Leuk Lymphoma; 1993; 11 Suppl 1():159-68. PubMed ID: 8251890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
